Trade

with

AstraZeneca PLC
(NYSE: AZN)
AdChoices
69.13
+0.35
+0.51%
After Hours :
-
-
-

Open

69.04

Previous Close

68.78

Volume (Avg)

243.97k (2.47M)

Day's Range

68.97-69.19

52Wk Range

51.92-82.68

Market Cap.

87.13B

Dividend Rate (Yield )

2.80 (4.06%)

Beta

0.56

Shares Outstanding

1.26B

P/E Ratio (EPS)

42.92 (1.61)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 25.71B

    • Net Income

    • 2.56B

    • Market Cap.

    • 87.13B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 7.79

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.56

    • Forward P/E

    • 15.60

    • Price/Sales

    • 3.34

    • Price/Book Value

    • 3.94

    • Price/Cash flow

    • 12.47

      • EBITDA

      • 8.35B

      • Return on Capital %

      • 3.59

      • Return on Equity %

      • 8.94

      • Return on Assets %

      • 3.59

      • Book Value/Share

      • 17.45

      • Shares Outstanding

      • 1.26B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.90 (8/13/2014)

      • Dividend Declaration Date

      • 7/31/2014

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 65.97

        • Credit Rating

        • AA-

        • Analysts

        • 6

        • EPS Estimate

        • 2.20

        • Cashflow Estimate

        • 5.96

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 3.60

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -59.40

          • 7.80

          • Net Income

            Q/Q (last year)

          • -3.30

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • -4.04

          • 6.10

          • Net Income

            5-Year Annual Average

          • -16.00

          • 3.73

          • Dividends

            5-Year Annual Average

          • 8.06

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 79.06

            • 69.92

            • Pre-Tax Margin

            • 9.17

            • 21.84

            • Net Profit Margin

            • 7.79

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 81.10

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 28.60

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 21.90

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.34

              • 0.32

              • Current Ratio

              • 0.99

              • 1.92

              • Quick Ratio

              • 0.85

              • 1.31

              • Interest Coverage

              • 4.28

              • 17.64

              • Leverage Ratio

              • 2.66

              • 2.03

              • Book Value/Share

              • 17.45

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 42.37

                • 22.12

                • P/E Ratio 5-Year High

                • 51.50

                • 193.96

                • P/E Ratio 5-Year Low

                • 24.74

                • 87.26

                • Price/Sales Ratio

                • 3.30

                • 3.75

                • Price/Book Value

                • 3.90

                • 3.75

                • Price/Cash Flow Ratio

                • 12.47

                • 14.03

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 174.41

                    • Dividend Date

                    • 7/31/2014

                    • Ex-Dividend Date

                    • 8/13/2014

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 8.94

                        (31.70)

                      • 17.42

                        (18.66)

                      • Return on Assets %

                        (5-Year Average)

                      • 3.59

                        (12.80)

                      • 8.45

                        (8.77)

                      • Return on Capital %

                        (5-Year Average)

                      • 8.04

                        (25.50)

                      • 12.41

                        (13.18)

                      • Income/Employee

                      • 39.26k

                      • 90.07k

                      • Inventory Turnover

                      • 2.51

                      • 2.46

                      • Asset Turnover

                      • 0.46

                      • 0.46

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      3.71B
                      Operating Margin
                      14.44
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      12.47
                      Ownership

                      Institutional Ownership

                      8.24%

                      Top 10 Institutions

                      4.08%

                      Mutual Fund Ownership

                      3.26%

                      Float

                      -

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Wellington™

                      •  

                        10,379,730

                      • -12.95

                      • 0.82

                      • Vanguard Wellesley Income

                      •  

                        2,471,160

                      • 1.75

                      • 0.20

                      • Fidelity® Ser Intrinsic Opportunities Fd

                      •  

                        1,900,000

                      • -36.67

                      • 0.15

                      • Vanguard Windsor™ Fund

                      •  

                        1,722,300

                      • -17.19

                      • 0.14

                      • VA CollegeAmerica Cap Income Builder

                      •  

                        1,558,200

                      • 0.00

                      • 0.12

                      • Hartford Dividend and Growth Fund

                      •  

                        1,466,065

                      • 0.00

                      • 0.12

                      • Vanguard Equity Income Fund

                      •  

                        1,422,549

                      • 2.60

                      • 0.11

                      • Fidelity® Select Pharmaceuticals Port

                      •  

                        1,079,100

                      • -4.46

                      • 0.09

                      • Putnam Fund for Growth and Income Fund

                      •  

                        1,027,100

                      • 6.51

                      • 0.08

                      • Hartford Dividend and Growth HLS Fund

                      •  

                        796,175

                      • 0.00

                      • 0.06

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Wellington Management Company, LLP

                      •  

                        26,479,835

                      • -20.18%

                      • 2.10

                      • Fidelity Management and Research Company

                      •  

                        4,416,288

                      • -39.64%

                      • 0.35

                      • Arrowstreet Capital Limited Partnership

                      •  

                        3,174,970

                      • -28.90%

                      • 0.25

                      • Schafer Cullen Capital Management Inc

                      •  

                        2,393,638

                      • -36.77%

                      • 0.19

                      • Putnam Investment Management,LLC

                      •  

                        2,322,143

                      • -5.02%

                      • 0.18

                      • JANE STREET GROUP, LLC

                      •  

                        1,885,178

                      • +2,760.71%

                      • 0.15

                      • Renaissance Technologies Corp

                      •  

                        1,794,800

                      • +25.60%

                      • 0.14

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Major

                      Type

                      Classic Growth

                      Style

                      Large Core

                      AstraZeneca PLC was incorporated in England and Wales on 17 June 1992. From February 1993 until April 1999, the Company was called Zeneca Group PLC. On 6 April 1999, the Company changed its name to AstraZeneca PLC. It is a biopharmaceutical company. The Company focuses on three important areas of healthcare: Cardiovascular and Metabolic disease (CVMD); Oncology; and Respiratory, Inflammation and Autoimmunity (RIA). The Company is also engaged in the Infection, Neuroscience and Gastrointestinal (ING) disease areas. It operates in more than 100 countries.

                      Key People

                      Pascal Soriot

                      CEO/Director

                      Mr. Leif Johansson

                      Chairman of the Board/Director

                      Marc Dunoyer

                      CFO/Director/Executive VP, Divisional

                      Mr David Nicholas Smith

                      Executive VP, Divisional

                      Mr. Paul Hudson

                      Executive VP, Geographical

                      • AstraZeneca PLC

                      • 2 Kingdom Street

                      • London, W2 6BD

                      • GBR.Map

                      • Phone: +44 2076048000

                      • Fax: -

                      • astrazeneca.com

                      Incorporated

                      1992

                      Employees

                      51,500

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: